#TalkClinicalTrials: Rare Disease, Hydroxychloroquine & COVID-19
Margaret French’s daughter has a rare disease known as Peroxisomal Biogenesis Disorder – Zellweger Spectrum Disorder (PBD-ZSD). To manage her symptoms, she receives the drug hydroxychloroquine, which is also being tested in COVID-19 clinical trials. Below, Margaret opens up about her family’s experience with clinical trials as well as her concerns about hydroxychloroquine as potential […]